J. Goldman & Co’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Hold	0	–	–	–	550
2025 Q3	–	Sell	-164,278	Closed	-$3.89M	–	447
2025 Q2	$3.54M	Buy	+164,278	New	+$3.05M	0.11%	232
2025 Q1	–	Hold	0	–	–	–	466
2024 Q4	–	Hold	0	–	–	–	441
2023 Q3	–	Hold	0	–	–	–	354
2023 Q2	–	Hold	0	–	–	–	370
2023 Q1	–	Hold	0	–	–	–	350
2022 Q3	–	Hold	0	–	–	–	382
2022 Q2	–	Hold	0	–	–	–	353
2022 Q1	–	Hold	0	–	–	–	357
2021 Q2	–	Sell	-8,647	Closed	-$223K	–	392
2021 Q1	$223K	Buy	+8,647	New	+$381K	0.01%	395
2019 Q2	–	Sell	-15,644	Closed	-$420K	–	260
2019 Q1	$420K	Buy	+15,644	New	+$365K	0.04%	239
2018 Q3	–	Sell	-123,769	Closed	-$1.89M	–	253
2018 Q2	$1.89M	Buy	+123,769	New	+$2.21M	0.17%	210